Comparison of Efficacy and Safety of Vita 6 Versus Zinc Along With Applied Behavioural Therapy
Comparison of Efficacy and Safety of Vita 6 Versus Zinc Along With Applied Behavioural Therapy in Management of Autism Spectrum Disorder in Children Aged 3-14 Years
Muhammad Aamir Latif
64 participants
Sep 23, 2025
INTERVENTIONAL
Conditions
Summary
The study seeks to fill the gaps in available local data regarding the diagnosis and its management, as multiple treatments are in practice. Therefore, the study aimed at the comparison of efficacy and safety of Vita 6 versus zinc along with applied behavioral therapy in the management of autism spectrum disorder in children aged 3-14 years.
Eligibility
Inclusion Criteria4
- Children of any gender
- Aged 3-12 years
- Newly diagnosed patients of autism spectrum disorder following the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria
- Not taking any treatment
Exclusion Criteria2
- With any of psychiatric disorder
- With any of movement disorder
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will be given one tablet of Vita 6 (50 mg) twice a day for 3 months, along with applied behavioral therapy.
Patients will receive syrup zinc sulfate 2 mg/kg/day as a single dose for 3 months, along with applied behavioral therapy.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07383363